Dopamine receptors and key elements of the neurotrophins (BDNF, CDNF) expression patterns during critical periods of ontogenesis in the brain structures of mice with autism-like behavior (BTBR) or its absence (С57BL/6J)

Analysis of the mechanisms underlying autism spectrum disorder (ASD) is an urgent task due to the everincreasing prevalence of this condition. The study of critical periods of neuroontogenesis is of interest, since the manifestation of ASD is often associated with prenatal disorders of the brain development. One of the currently promising hypotheses postulates a connection between the pathogenesis of ASD and the dysfunction of neurotransmitters and neurotrophins. In this study, we investigated the expression of key dopamine receptors (Drd1, Drd2), brain-derived neurotrophic factor (Bdnf), its receptors (Ntrkb2, Ngfr) and the transcription factor Creb1 that mediates BDNF action, as well as cerebral dopamine neurotrophic factor (Cdnf) during the critical periods of embryogenesis (e14 and e18) and postnatal development (p14, p28, p60) in the hippocampus and frontal cortex of BTBR mice with autism-like behavior compared to the neurotypical C57BL/6 J strain. In BTBR embryos, on the 14th day of prenatal development, an increase in the expression of the Ngfr gene encoding the p75NTR receptor, which may lead to the activation of apoptosis, was found in the hippocampus and frontal cortex. A decrease in the expression of Cdnf, Bdnf and its receptor Ntrkb2, as well as dopamine receptors (Drd1, Drd2) was detected in BTBR mice in the postnatal period of ontogenesis mainly in the frontal cortex, while in the hippocampus of mature mice (p60), only a decrease in the Drd2 mRNA level was revealed. The obtained results suggest that the decrease in the expression levels of CDNF, BDNF-TrkB and dopamine receptors in the frontal cortex in the postnatal period can lead to significant changes in both the morphology of neurons and dopamine neurotransmission in cortical brain structures. At the same time, the increase in p75NTR receptor gene expression observed on the 14th day of embryogenesis, crucial for hippocampus and frontal cortex development, may have direct relevance to the manifestation of early autism.

1. Adhya D., Swarup V., Nagy R., Dutan L., Shum C., Valencia-Alarcуn E.P., Jozwik K.M., Mendez M.A., Horder J., Loth E., Nowosiad P., Lee I., Skuse D., Flinter F.A., Murphy D., McAlonan G., Geschwind D.H., Price J., Carroll J., Srivastava D.P., Baron-Cohen S. Atypical neurogenesis in induced pluripotent stem cells from autistic individuals. Biol. Psychiatry. 2021;89(5):486-496. DOI 10.1016/j.biopsych.2020.06.014

2. Aljanabi S.M., Martinez I. Universal and rapid salt-extraction of high quality genomic DNA for PCR-based techniques. Nucleic Acids Res. 1997;25(22):4692-4693. DOI 10.1093/nar/25.22.4692

3. Anghelescu I., Dettling M. Neuron number in children with autism. JAMA. 2012;307(8):783. DOI 10.1001/jama.2012.191

4. Belokopytova I.I., Kondaurova E.M., Kulikova E.A., Ilchibaeva T.V., Naumenko V.S., Popova N.K. Effects of the Cc2d1a/Freud-1 knockdown in the hippocampus of BTBR mice on the autistic-like behavior, expression of serotonin 5-HT1A and D2 dopamine receptors, and CREB and NF-κB intracellular signaling. Biochemistry (Mosc.). 2022;87(10):1206-1218. DOI 10.1134/S0006297922100145

5. Bohlen M.O., Bailoo J.D., Jordan R.L., Wahlsten D. Hippocampal commissure defects in crosses of four inbred mouse strains with absent corpus callosum. Genes Brain Behav. 2012;11(7):757-766. DOI 10.1111/j.1601-183X.2012.00802.x

6. Boћok V., Yu L.Y., Palgi J., Arumӓe U. Antioxidative CXXC peptide motif from mesencephalic astrocyte-derived neurotrophic factor antagonizes programmed cell death. Front. Cell Dev. Biol. 2018;6:106. DOI 10.3389/fcell.2018.00106

7. Bolivar V.J., Walters S.R., Phoenix J.L. Assessing autism-like behavior in mice: variations in social interactions among inbred strains. Behav. Brain Res. 2007;176(1):21-26. DOI 10.1016/j.bbr.2006.09.007

8. Castrén E., Antila H. Neuronal plasticity and neurotrophic factors in drug responses. Mol. Psychiatry. 2017;22(8):1085-1095. DOI 10.1038/mp.2017.61

9. Cellot G., Maggi L., Di Castro M.A., Catalano M., Migliore R., Migliore M., Scattoni M.L., Calamandrei G., Cherubini E. Premature changes in neuronal excitability account for hippocampal network impairment and autistic-like behavior in neonatal BTBR T+tf/J mice. Sci. Rep. 2016;6:31696. DOI 10.1038/srep31696

10. Chen V.S., Morrison J.P., Southwell M.F., Foley J.F., Bolon B., Elmore S.A. Histology atlas of the developing prenatal and postnatal mouse central nervous system, with emphasis on prenatal days E7.5 to E18.5. Toxicol. Pathol. 2017;45(6):705-744. DOI 10.1177/0192623317728134

11. Courchesne E., Mouton P.R., Calhoun M.E., Semendeferi K., AhrensBarbeau C., Hallet M.J., Barnes C.C., Pierce K. Neuron number and size in prefrontal cortex of children with autism. JAMA. 2011; 306(18):2001-2010. DOI 10.1001/jama.2011.1638

12. Courchesne E., Pramparo T., Gazestani V.H., Lombardo M.V., Pierce K., Lewis N.E. The ASD Living Biology: from cell proliferation to clinical phenotype. Mol. Psychiatry. 2019;24(1):88-107. DOI 10.1038/s41380-018-0056-y

13. Courchesne E., Gazestani V.H., Lewis N.E. Prenatal origins of ASD: The when, what, and how of ASD development. Trends Neurosci. 2020;43(5):326-342. DOI 10.1016/j.tins.2020.03.005

14. Crandall J.E., McCarthy D.M., Araki K.Y., Sims J.R., Ren J.Q., Bhide P.G. Dopamine receptor activation modulates GABA neuron migration from the basal forebrain to the cerebral cortex. J. Neurosci. 2007;27(14):3813-3822. DOI 10.1523/JNEUROSCI.5124- 06.2007

15. Crawley J.N. Twenty years of discoveries emerging from mouse models of autism. Neurosci. Biobehav. Rev. 2023;146:105053. DOI 10.1016/j.neubiorev.2023.105053

16. DiCarlo G.E., Aguilar J.I., Matthies H.J., Harrison F.E., Bundschuh K.E., West A., Hashemi P., Herborg F., Rickhag M., Chen H., Gether U., Wallace M.T., Galli A. Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors. J. Clin. Invest. 2019;129(8):3407- 3419. DOI 10.1172/JCI127411

17. Enticott P.G., Kennedy H.A., Rinehart N.J., Tonge B.J., Bradshaw J.L., Fitzgerald P.B. GABAergic activity in autism spectrum disorders: an investigation of cortical inhibition via transcranial magnetic stimulation. Neuropharmacology. 2013;68:202-209. DOI 10.1016/j.neuropharm.2012.06.017

18. Fenner B.M. Truncated TrkB: beyond a dominant negative receptor. Cytokine Growth Factor Rev. 2012;23(1-2):15-24. DOI 10.1016/j.cytogfr.2012.01.002

19. Finlay B.L., Darlington R.B. Linked regularities in the development and evolution of mammalian brains. Science. 1995;268(5217): 1578-1584. DOI 10.1126/science.7777856

20. Frazier T.W., Hardan A.Y. A meta-analysis of the corpus callosum in autism. Biol. Psychiatry. 2009;66(10):935-941. DOI 10.1016/j.biopsych.2009.07.022

21. Garcia K.L., Yu.G., Nicolini C., Michalski B., Garzon D.J., Chiu V.S., Tongiorgi E., Szatmari P., Fahnestock M. Altered balance of proteolytic isoforms of pro-brain-derived neurotrophic factor in autism. J. Neuropathol. Exp. Neurol. 2012;71(4):289-297. DOI 10.1097/NEN.0b013e31824b27e4

22. Hashem S., Nisar S., Bhat A.A., Yadav S.K., Azeem M.W., Bagga P., Fakhro K., Reddy R., Frenneaux M.P., Haris M. Genetics of structural and functional brain changes in autism spectrum disorder. Transl. Psychiatry. 2020;10(1):229. DOI 10.1038/s41398-020-00921-3

23. Hettinger J.A., Liu X., Schwartz C.E., Michaelis R.C., Holden J.J. A DRD1 haplotype is associated with risk for autism spectrum disorders in male-only affected sib-pair families. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008;147B(5):628-636. DOI 10.1002/ajmg.b.30655

24. Ilchibaeva T., Tsybko A., Lipnitskaya M., Eremin D., Milutinovich K., Naumenko V., Popova N. Brain-derived neurotrophic factor (BDNF) in mechanisms of autistic-like behavior in BTBR mice: crosstalk with the dopaminergic brain system. Biomedicines. 2023;11(5):1482. DOI 10.3390/biomedicines11051482

25. Kanner L. Autistic disturbances of affective contact. Nervous Child. 1943;2:217-250

26. Kemper T.L., Bauman M. Neuropathology of infantile autism. J. Neuropathol. Exp. Neurol. 1998;57(7):645-652. DOI 10.1097/00005072-199807000-00001

27. Kondaurova E.M., Plyusnina A.V., Ilchibaeva T.V., Eremin D.V., Rodnyy A.Y., Grygoreva Y.D., Naumenko V.S. Effects of a Cc2d1a/ Freud-1 knockdown in the hippocampus on behavior, the serotonin system, and BDNF. Int. J. Mol. Sci. 2021;22(24):13319. DOI 10.3390/ijms222413319

28. Koshimizu H., Kiyosue K., Hara T., Hazama S., Suzuki S., Uegaki K., Nagappan G., Zaitsev E., Hirokawa T., Tatsu Y., Ogura A., Lu B., Kojima M. Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. Mol. Brain. 2009;2:27. DOI 10.1186/1756-6606-2-27

29. Krishnan A., Zhang R., Yao V., Theesfeld C.L., Wong A.K., Tadych A., Volfovsky N., Packer A., Lash A., Troyanskaya O.G. Genome-wide prediction and functional characterization of the genetic basis of autism spectrum disorder. Nat. Neurosci. 2016;19(11):1454-1462. DOI 10.1038/nn.4353

30. Kulikov A.V., Naumenko V.S., Voronova I.P., Tikhonova M.A., Popova N.K. Quantitative RT-PCR assay of 5-HT1A and 5-HT2A serotonin receptor mRNAs using genomic DNA as an external standard. J. Neurosci. Methods. 2005;141(1):97-101. DOI 10.1016/j.jneumeth.2004.06.005

31. Küppers E., Beyer C. Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells. Neuroreport. 2001;12(6):1175-1179. DOI 10.1097/00001756-200105080-00025

32. Lessmann V., Gottmann K., Malcangio M. Neurotrophin secretion: current facts and future prospects. Prog. Neurobiol. 2003;69(5):341- 374. DOI 10.1016/s0301-0082(03)00019-4

33. Lindholm P., Saarma M. Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism. Mol. Psychiatry. 2022;27(3):1310-1321. DOI 10.1038/s41380-021-01394-6

34. Lindholm P., Voutilainen M.H., Laurén J., Peränen J., Leppänen V.M., Andressoo J.O., Lindahl M., Janhunen S., Kalkkinen N., Timmusk T., Tuominen R.K., Saarma M. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature. 2007;448(7149):73-77. DOI 10.1038/nature05957

35. Lindholm P., Peränen J., Andressoo J.O., Kalkkinen N., Kokaia Z., Lindvall O., Timmusk T., Saarma M. MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain. Mol. Cell. Neurosci. 2008;39(3): 356-371. DOI 10.1016/j.mcn.2008.07.016

36. Liu S.H., Shi X.J., Fan F.C., Cheng Y. Peripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis. Sci. Rep. 2021;11(1):15. DOI 10.1038/s41598-020-79080-w

37. Loones M.T., Chang Y., Morange M. The distribution of heat shock proteins in the nervous system of the unstressed mouse embryo suggests a role in neuronal and non-neuronal differentiation. Cell Stress Chaperones. 2000;5(4):291-305. DOI 10.1379/1466-1268(2000)005<0291:tdohsp>2.0.co;2

38. Lu B., Pang P.T., Woo N.H. The yin and yang of neurotrophin action. Nat. Rev. Neurosci. 2005;6(8):603-614. DOI 10.1038/nrn1726

39. Mangale V.S., Hirokawa K.E., Satyaki P.R., Gokulchandran N., Chikbire S., Subramanian L., Shetty A.S., Martynoga B., Paul J., Mai M.V., Li Y., Flanagan L.A., Tole S., Monuki E.S. Lhx2 selector activity specifies cortical identity and suppresses hippocampal organizer fate. Science. 2008;319(5861):304-309. DOI 10.1126/science.1151695

40. Mariani J., Coppola G., Zhang P., Abyzov A., Provini L., Tomasini L., Amenduni M., Szekely A., Palejev D., Wilson M., Gerstein M., Grigorenko E.L., Chawarska K., Pelphrey K.A., Howe J.R., Vaccarino F.M. FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders. Cell. 2015;162(2):375- 390. DOI 10.1016/j.cell.2015.06.034

41. McFarlane H.G., Kusek G.K., Yang M., Phoenix J.L., Bolivar V.J., Crawley J.N. Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav. 2008;7(2):152-163. DOI 10.1111/j.1601-183X.2007.00330.x

42. Minshew N.J., Williams D.L. The new neurobiology of autism: cortex, connectivity, and neuronal organization. Arch. Neurol. 2007;64(7): 945-950. DOI 10.1001/archneur.64.7.945

43. Naumenko V.S., Kulikov A.V. Quantitative assay of 5-HT1A receptor gene expression in the brain. Mol. Biol. (Mosk.). 2006;40(1):30-36. DOI 10.1134/S0026893306010067

44. Naumenko V.S., Osipova D.V., Kostina E.V., Kulikov A.V. Utilization of a two-standard system in real-time PCR for quantification of gene expression in the brain. J. Neurosci. Methods. 2008;170(2):197-203. DOI 10.1016/j.jneumeth.2008.01.008

45. Neal M., Cunningham J., Lever I., Pezet S., Malcangio M. Mechanism by which brain-derived neurotrophic factor increases dopamine release from the rabbit retina. Invest. Ophthalmol. Vis. Sci. 2003; 44(2):791-798. DOI 10.1167/iovs.02-0557

46. Nguyen H.T.N., Kato H., Masuda K., Yamaza H., Hirofuji Y., Sato H., Pham T.T.M., Takayama F., Sakai Y., Ohga S., Taguchi T., Nonaka K. Impaired neurite development associated with mitochondrial dysfunction in dopaminergic neurons differentiated from exfoliated deciduous tooth-derived pulp stem cells of children with autism spectrum disorder. Biochem. Biophys. Rep. 2018;16:24-31. DOI 10.1016/j.bbrep.2018.09.004

47. Palasz E., Wysocka A., Gasiorowska A., Chalimoniuk M., Niewiadomski W., Niewiadomska G. BDNF as a promising therapeutic agent in Parkinson’s disease. Int. J. Mol. Sci. 2020;21(3):1170. DOI 10.3390/ijms21031170

48. Pavăl D. A Dopamine hypothesis of autism spectrum disorder. Dev. Neurosci. 2017;39(5):355-360. DOI 10.1159/000478725

49. Popolo M., McCarthy D.M., Bhide P.G. Influence of dopamine on precursor cell proliferation and differentiation in the embryonic mouse telencephalon. Dev. Neurosci. 2004;26(2-4):229-244. DOI 10.1159/00008214

50. Popova N.K., Naumenko V.S. Neuronal and behavioral plasticity: the role of serotonin and BDNF systems tandem. Expert Opin. Ther. Targets. 2019;23(3):227-239. DOI 10.1080/14728222.2019.1572747

51. Pourhamzeh M., Moravej F.G., Arabi M., Shahriari E., Mehrabi S., Ward R., Ahadi R., Joghataei M.T. The roles of serotonin in neuropsychiatric disorders. Cell. Mol. Neurobiol. 2022;42(6):1671-1692. DOI 10.1007/s10571-021-01064-9

52. Richards L.J., Plachez C., Ren T. Mechanisms regulating the development of the corpus callosum and its agenesis in mouse and human. Clin. Genet. 2004;66(4):276-289. DOI 10.1111/j.1399-0004.2004.00354.x

53. Rochefort N.L., Garaschuk O., Milos R.I., Narushima M., Marandi N., Pichler B., Kovalchuk Y., Konnerth A. Sparsification of neuronal activity in the visual cortex at eye-opening. Proc. Natl. Acad. Sci. USA. 2009;106(35):15049-15054. DOI 10.1073/pnas.0907660106

54. Rodnyy A.Y., Kondaurova E.M., Tsybko A.S., Popova N.K., Kudlay D.A., Naumenko V.S. The brain serotonin system in autism. Rev. Neurosci. 2023;35(1):1-20. DOI 10.1515/revneuro-2023-0055

55. Sacco R., Gabriele S., Persico A.M. Head circumference and brain size in autism spectrum disorder: A systematic review and metaanalysis. Psychiatry Res. 2015;234(2):239-251. DOI 10.1016/j.pscychresns.2015.08.016

56. Satterstrom F.K., Kosmicki J.A., Wang J., Breen M.S., De Rubeis S., An J.Y., Peng M., … Guerrero E.E., Dias C.; Autism Sequencing Consortium; iPSYCH-Broad Consortium; Betancur C., Cook E.H., Gallagher L., Gill M., Sutcliffe J.S., Thurm A., Zwick M.E., Børglum A.D., State M.W., Cicek A.E., Talkowski M.E., Cutler D.J., Devlin B., Sanders S.J., Roeder K., Daly M.J., Buxbaum J.D. Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell. 2020; 180(3):568-584.e23. DOI 10.1016/j.cell.2019.12.036

57. Segura M., Pedreño C., Obiols J., Taurines R., Pаmias M., Grünblatt E., Gella A. Neurotrophin blood-based gene expression and social cognition analysis in patients with autism spectrum disorder. Neurogenetics. 2015;16(2):123-131. DOI 10.1007/s10048-014-0434-9

58. Staal W.G., Langen M., van Dijk S., Mensen V.T., Durston S. DRD3 gene and striatum in autism spectrum disorder. Br. J. Psychiatry. 2015;206(5):431-432. DOI 10.1192/bjp.bp.114.148973

59. Teng H.K., Teng K.K., Lee R., Wright S., Tevar S., Almeida R.D., Kermani P., Torkin R., Chen Z.Y., Lee F.S., Kraemer R.T., Nykjaer A., Hempstead B.L. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 2005;25(22):5455-5463. DOI 10.1523/JNEUROSCI.5123-04.2005

60. Voutilainen M.H., Bäck S., Peränen J., Lindholm P., Raasmaja A., Männistö P.T., Saarma M., Tuominen R.K. Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson’s disease. Exp. Neurol. 2011;228(1):99-108. DOI 10.1016/j.expneurol.2010.12.013

61. Wambach C.M., Patel S.N., Kahn D.A. Maternal and fetal factors that contribute to the localization of T regulatory cells during pregnancy. Am. J. Reprod. Immunol. 2014;71(5):391-400. DOI 10.1111/aji.12223

62. Wei H., Alberts I., Li X. The apoptotic perspective of autism. Int. J. Dev. Neurosci. 2014;36:13-18. DOI 10.1016/j.ijdevneu.2014.04.004

63. Yang J., Siao C.J., Nagappan G., Marinic T., Jing D., McGrath K., Chen Z.Y., Mark W., Tessarollo L., Lee F.S., Lu B., Hempstead B.L. Neuronal release of proBDNF. Nat. Neurosci. 2009;12(2):113-115. DOI 10.1038/nn.2244

64. Yoo H.J., Cho I.H., Park M., Yang S.Y., Kim S.A. Association of the catechol-o-methyltransferase gene polymorphisms with Korean autism spectrum disorders. J. Korean Med. Sci. 2013;28(9):1403- 1406. DOI 10.3346/jkms.2013.28.9.1403